Dupont Capital Management Corp Medpace Holdings, Inc. Transaction History

Dupont Capital Management Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$187.26 - $240.17 $252,426 - $323,749	1,348 New	1,348 $323,000
Q4 2022 Jan 26, 2023	SELL	$153.06 - $226.57 $965,961 - $1.43 Million	-6,311 Reduced 83.97%	1,205 $0
Q3 2022 Oct 31, 2022	BUY	$145.13 - $182.49 $820,855 - $1.03 Million	5,656 Added 304.09%	7,516 $1.18 Million
Q2 2022 Jul 26, 2022	SELL	$130.2 - $168.03 $188,008 - $242,635	-1,444 Reduced 43.7%	1,860 $278,000
Q1 2022 Apr 27, 2022	SELL	$138.87 - $214.31 $40,688 - $62,792	-293 Reduced 8.15%	3,304 $541,000

Q4 2021 Jan 31, 2022	SELL	$182.74 - $227.9 $209,237 - $260,945	-1,145 Reduced 24.15%	3,597 $783,000
Q3 2021 Nov 03, 2021	BUY	$170.18 - $198.21 $263,268 - $306,630	1,547 Added 48.42%	4,742 $898,000
Q1 2021 Apr 29, 2021	SELL	$132.02 - $168.26 $908,561 - $1.16 Million	-6,882 Reduced 68.29%	3,195 $524,000
Q4 2020 Jan 28, 2021	SELL	$109.38 - $149.19 $1.31 Million - $1.78 Million	-11,939 Reduced 54.23%	10,077 $1.4 Million
Q3 2020 Oct 29, 2020	BUY	$92.95 - $130.61 $1.55 Million - $2.17 Million	16,640 Added 309.52%	22,016 $2.46 Million
Q2 2020 Jul 24, 2020	SELL	$68.08 - $95.68 $151,614 - $213,079	-2,227 Reduced 29.29%	5,376 $500,000
Q1 2020 Apr 29, 2020	SELL	$61.71 - $101.95 $501,825 - $829,057	-8,132 Reduced 51.68%	7,603 $558,000
Q3 2019 Oct 28, 2019	BUY	$62.38 - $85.89 $371,410 - $511,389	5,954 Added 60.87%	15,735 $1.32 Million
Q4 2018 Feb 01, 2019	BUY	$46.97 - $63.98 $138,843 - $189,124	2,956 Added 43.31%	9,781 $518,000
Q3 2018 Nov 05, 2018	BUY	$43.25 - $63.74 $295,181 - $435,025	6,825 New	6,825 $409,000

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.